Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alzinova AB | 265,352 | net | 20 Feb 2026 | tx 5+265,352 |
| Elicera Therapeutics AB | 49,900 | net | 11 Mar 2025 | tx 5+49,900 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | PURCHASE | Alzinova AB | 4,010 | 2.40 SEK | |
| 06 May 2025 | PURCHASE | Alzinova AB | 3,342 | 2.00 SEK | |
| 04 Apr 2025 | GRANT_AWARD | Alzinova AB | 250,000 | 0.26 SEK | deriv |
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 21,700 | 1.85 SEK | first after silence |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 3,100 | 16.20 SEK | first after silence |
| 17 Apr 2023 | OTHER | Alzinova AB | 4,000 | 2.17 SEK | |
| 13 Apr 2023 | OTHER | Alzinova AB | 4,000 | 2.17 SEK | deriv |
| 05 Jul 2021 | PURCHASE | Elicera Therapeutics AB | 12,100 | 4.30 SEK | |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 6,500 | 8.00 SEK | |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 6,500 | 0.00 SEK | deriv |
2 purchases reported after at least 12 months of silence — most recent on 11 Mar 2025.